Annika Kim Constantino is a Digital Reporter at CNBC. She covers the biotech and pharmaceutical industry, focusing on themes such as medicine and healthcare, alternative medicine, and e-commerce. Annika's work has been featured in outlets including San Diego Live Sound, NBC Connecticut, NBC News, and Yahoo News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Annika Kim Constantino's coverage primarily focuses on the healthcare and pharmaceutical industry within the United States. She frequently cites data, reports on government announcements, and incorporates press releases into her articles.
Given this focus, she may be receptive to pitches from experts in the healthcare and pharmaceutical industries who can provide analysis or commentary on drug approvals, vaccine development, health regulations, company news (especially those related to U.S.-based companies), patent challenges, or other relevant topics within the realm of healthcare and pharmaceuticals.
Pitches offering insights based on solid data or relating to recent government announcements in the U.S. healthcare sector would likely align well with Annika's coverage preferences.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Melissa Repko, Annika Kim Constantino
Walmart will start delivering medications in six states, but plans to offer prescription delivery in nearly every state by the end of January.
By: Annika Kim Constantino
The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely.
By: Annika Kim
Key Points It is the latest tally of people affected since the agency announced the outbreak on Tuesday, citing 49 cases and one death across 10 states.
By: Annika Kim Constantino
The CDC believes the risk to the public is "very low" due to the actions taken by McDonald's and Taylor Farms to remove slivered onions from affected locations.
By: Annika Kim, Ashley Capoot
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox.
By: Annika Kim, Ashley Capoot
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox.
Key Points Shares of Amgen fell as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide.
By: Annika Kim Constantino, Ashley Capoot
AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to purchase Summa Health for $485 million.
Key Points President-elect Donald Trump has anyone tapped Robert F. Kennedy Jr., a notorious vaccine skeptic, to lead the Department of Health and Human Services.
By: Ashley Capoot, Annika Kim Constantino
Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.
(833) 317-6278 
